The Dysregulation of the Glymphatic System in Patients with Psychosis Spectrum Disorders Minimally Exposed to Antipsychotics

被引:0
|
作者
Korann, Vittal [1 ,2 ]
Panganiban, Kristoffer J. [1 ,2 ]
Stogios, Nicolette [1 ]
Remington, Gary [1 ,2 ,3 ,4 ]
Graff-Guerrero, Ariel [2 ,3 ,4 ,5 ]
Chintoh, Araba [1 ,3 ]
Hahn, Margaret K. [1 ,2 ,3 ,6 ]
Agarwal, Sri Mahavir [1 ,2 ,3 ,6 ]
机构
[1] Ctr Addict & Mental Hlth, Schizophrenia Div, Toronto, ON, Canada
[2] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychiat, 1051 Queen St West, Toronto, ON M6J 1H3, Canada
[4] Univ Toronto Scarborough, Dept Psychol Clin Sci, Toronto, ON, Canada
[5] Ctr Addict & Mental Hlth, Res Imaging Ctr, Multimodal Imaging Grp, Toronto, ON, Canada
[6] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON, Canada
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2024年
基金
加拿大健康研究院;
关键词
psychosis; schizophrenia; DTI-ALPS; antipsychotic-minimally exposed; glymphatic system; SCHIZOPHRENIA; CLEARANCE; DISEASE; MATTER; SLEEP;
D O I
10.1177/07067437241290193
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The pathophysiological mechanisms influencing psychosis spectrum disorders are largely unknown. The glymphatic system, which is a brain waste clearance pathway, has recently been implicated in its pathophysiology and has also been shown to be disrupted in various neurodegenerative and vascular diseases. Initial studies examining the glymphatic system in psychosis spectrum disorders have reported disruptions, but the findings have been confounded by medication effects as they included antipsychotic-treated patients. In this study, we used diffusion tensor imaging analysis along the perivascular space (DTI-ALPS) as a technique to measure the functionality of the glymphatic system in a sample of antipsychotic-minimally exposed patients with psychosis spectrum disorders and healthy controls. Methods: The study included 13 antipsychotic-minimally exposed (2 weeks antipsychotic exposure in the past 3 months/lifetime) patients with psychosis spectrum disorders and 114 healthy controls. We quantified water diffusion metrics along the x-, y-, and z-axes in both projection and association fibres to derive the DTI-ALPS index, a proxy for glymphatic activity. Between-group differences were analyzed using two-way ANCOVA controlling for age and sex. Partial correlations were used to assess the association between the ALPS index and clinical variables. Results: Analyses revealed that antipsychotic-minimally exposed psychosis spectrum disorder patients had a lower DTI-ALPS index value than healthy controls in both hemispheres and the whole brain (all P < 0.005). Significant differences were also observed between the x and y projections/associations between patients and healthy controls (P < 0.001). Furthermore, we did not find any significant correlations (all P > 0.05) between the DTI-ALPS index with age, body mass index, symptomatology, and metabolic parameters. Conclusion: This study shows that the glymphatic system is dysregulated in antipsychotic-minimally exposed patients with psychosis spectrum disorders. Understanding the mechanisms that influence the glymphatic system may help to understand the pathophysiology of psychosis spectrum disorders as proper waste clearance is needed for normal brain functioning.
引用
收藏
页数:11
相关论文
共 32 条
  • [1] The selective effect of antipsychotics on the different dimensions of the experience of psychosis in schizophrenia spectrum disorders
    Mizrahi, Romina
    Kiang, Michael
    Mamo, David C.
    Arenovich, Tamara
    Bagby, R. Michael
    Zipursky, Robert B.
    Kapur, Shitij
    SCHIZOPHRENIA RESEARCH, 2006, 88 (1-3) : 111 - 118
  • [2] Association of the PPAR-γ Gene with Altered Glucose Levels and Psychosis Profile in Schizophrenia Patients Exposed to Antipsychotics
    Liu, Yun-Ru
    Hu, Tsung-Ming
    Lana, Tsuo-Hung
    Chiu, Hsien-Jane
    Chang, Yung-Han
    Chen, Shuo-Fei
    Yull, Yen-Hsin
    Chen, Cheng-Chung
    Loh, El-Wui
    PSYCHIATRY INVESTIGATION, 2014, 11 (02) : 179 - 185
  • [3] Validation of the dimensions of psychosis instrument in Mexican patients with schizophrenia spectrum disorders
    Leon-Ortiz, Pablo
    Fresan, Ana
    Stephano, Sylvana
    de la Fuente-Sandoval, Camilo
    SCHIZOPHRENIA RESEARCH, 2011, 132 (2-3) : 153 - 156
  • [4] The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: Protocol for a systematic review and meta-analysis
    Druyts E.
    Eapen S.
    Wu P.
    Thorlund K.
    Systematic Reviews, 3 (1)
  • [5] Lesion network guided delta frequency neuromodulation improves cognition in patients with psychosis spectrum disorders: A pilot study
    Molho, Willa
    Raymond, Nicolas
    Reinhart, Robert M. G.
    Trotti, Rebekah
    Grover, Shrey
    Keshavan, Matcheri
    Lizano, Paulo
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 92
  • [6] Text Message Reminders for Long-Acting Injectable Antipsychotics in Patients with Schizophrenia Spectrum Disorders
    Chen, Christina J.
    Hilliard, Wanda
    JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2024, 30 (04) : 828 - 833
  • [7] Intensive Longitudinal Social Sensing in Patients With Psychosis Spectrum Disorders: An Exploratory Pilot Study
    von Heyden, Moritz
    Grube, Paul
    Sack, Markus
    Wiesner, Johannes
    Frank, Oliver
    Becker, Kathrin
    Heintz, Stefan
    Reinhard, Iris
    Hohmann, Sarah
    Hirjak, Dusan
    Meyer-Lindenberg, Andreas
    Braun, Urs
    SCHIZOPHRENIA BULLETIN, 2024, 51 (01) : 236 - 246
  • [8] Maintenance Therapy of Psychosis Spectrum Disorders in a Real-World Setting: Antipsychotics Prescription Patterns and Long-Term Benzodiazepine Use
    Maric, Nadja P.
    Andric Petrovic, Sanja
    Russo, Manuela
    Jerotic, Stefan
    Ristic, Ivan
    Savic, Bojana
    Pemovska, Tamara
    Milutinovic, Milos
    Ribic, Emina
    Markovska-Simoska, Silvana
    Dzubur Kulenovic, Alma
    Jovanovic, Nikolina
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [9] Atypical antipsychotics in the treatment of patients with a dual diagnosis of schizophrenia spectrum disorders and substance use disorders: the results of a randomized comparative study
    Skryabin, V. Yu.
    Vinnikova, M. A.
    Ezhkova, E. V.
    Titkov, M. S.
    Bulatova, R. A.
    JOURNAL OF ADDICTIVE DISEASES, 2021, 39 (04) : 513 - 525
  • [10] Quantitative Resting State Electroencephalography in Patients with Schizophrenia Spectrum Disorders Treated with Strict Monotherapy Using Atypical Antipsychotics
    Ozaki, Takashi
    Toyomaki, Atsuhito
    Hashimoto, Naoki
    Kusumi, Ichiro
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2021, 19 (02) : 313 - 322